Cancer vaccines: the next immunotherapy frontier

2022/08/23 by Matthew Lin, Matthew J. Lin, Judit Svensson‐Arvelund +7 · 13 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches

paper · doi:10.1038/s43018-022-00418-6

crossref issued 2022/08/23 · crossref published 2022/08/23 · crossref published-online 2022/08/23 · openalex publication_date 2022/08/23 · crossref created 2022/08/23 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/30

Citations

• Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
• A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Cited by

• Neoantigens: promising targets for cancer therapy
• The Landmark Series: Cancer Vaccines for Solid Tumors
• epiGPTope: A Machine Learning-Based Epitope Generator and Classifier
• Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
• Cancer vaccines: from an immunology perspective
• Leveraging mRNA technology for antigen based immuno-oncology therapies
• Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors
• ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer
• Polymeric Nanoparticles for Drug Delivery
• Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
• Gastrointestinal cancer: molecular pathogenesis and targeted therapy
• Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
• mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives